Authors: BERRUTI A ZOLA P BUNIVA T BAU MG FARRIS A SAROBBA MG BOTTINI A TAMPELLINI M DURANDO A DESTEFANIS M MONZEGLIO C MORO G SUSSIO M PERRONI D DOGLIOTTI L

Citation: A. Berruti et al., PROGNOSTIC FACTORS IN METASTATIC BREAST-CANCER PATIENTS OBTAINING OBJECTIVE RESPONSE OR DISEASE STABILIZATION AFTER FIRST-LINE CHEMOTHERAPYWITH EPIRUBICIN - EVIDENCE FOR A POSITIVE EFFECT OF MAINTENANCE HORMONAL-THERAPY ON OVERALL SURVIVAL, Anticancer research, 17(4A), 1997, pp. 2763-2768

Authors: DOGLIOTTI L BERRUTI A BUNIVA T ZOLA P BAU MG FARRIS A SAROBBA MG BOTTINI A ALQUATI P DELTETTO F GOSSO P MONZEGLIO C MORO G SUSSIO M PERRONI D

Citation: L. Dogliotti et al., LONIDAMINE SIGNIFICANTLY INCREASES THE ACTIVITY OF EPIRUBICIN IN PATIENTS WITH ADVANCED BREAST-CANCER - RESULTS FROM A MULTICENTER PROSPECTIVE RANDOMIZED TRIAL, Journal of clinical oncology, 14(4), 1996, pp. 1165-1172

Authors: DOGLIOTTI L BERRUTI A BUNIVA T ZOLA P BAU MG FARRIS A SAROBBA MG BOTTINI A ALQUATI P DELTETTO F GOSSO P MONZEGLIO C MORO G SUSSIO M PERRONI D

Citation: L. Dogliotti et al., A RANDOMIZED COMPARISON OF HIGH-DOSE EPIRUBICIN VERSUS HIGH-DOSE EPIRUBICIN PLUS LONIDAMINE IN ADVANCED BREAST-CANCER PATIENTS - FIRST RESULTS FROM A COOPERATIVE GROUP-STUDY, International journal of oncology, 4, 1994, pp. 747-752

Authors: FARRIS A BISAIL M SAROBBA MG SANNA G SCOTTO T VALZELLI S INTINI C

Citation: A. Farris et al., CISPLATIN-VP16 ALTERNATING WITH CYCLOPHOSPHAMIDE-EPIRUBICIN VERSUS CYCLOPHOSPHAMIDE-EPIRUBICIN-VINCRISTINE IN SMALL-CELL LUNG-CANCER, Journal of chemotherapy, 5(5), 1993, pp. 344-347